Novogenia AG (MUN:7V0)
Germany · Delayed Price · Currency is EUR 7.05
0.00 (0.00%)
Last updated: Jul 15, 2026, 8:00 AM CET
Novogenia AG Market Cap
Novogenia AG has a market cap or net worth of €84.6 million as of July 15, 2026. Its market cap has decreased by -29.50% in one year.
Market Cap
84.60M
Enterprise Value
37.73M
Revenue
54.30M
Ranking
n/a
PE Ratio
155.10
Stock Price
€7.05
Market Cap Chart
Since November 2, 2021, Novogenia AG's market cap has increased from 21.30M to 84.60M, an increase of 297.18%. That is a compound annual growth rate of 34.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 84.60M | -9.03% |
| Dec 22, 2025 | 93.00M | -14.36% |
| Dec 29, 2023 | 108.60M | -21.30% |
| Dec 30, 2022 | 138.00M | 88.52% |
| Dec 13, 2021 | 73.20M | 243.66% |
| Nov 2, 2021 | 21.30M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biotest GmbH & Co. KGaA | 1.31B |
| 2invest AG | 45.07M |
| Biomark Diagnostics | 33.65M |
| Vidac Pharma Holding | 24.83M |
| Paion AG | 435.16K |
| co.don AG | 334.04K |
| bioXXmed AG | 209.34K |
| MagForce AG | 91.72K |